abagovomab 20
abciximab 21
abituzumab 12
abrilumab 12
actoxumab 8
adalimumab 9
aducanumab 5
afasevikumab 3
alacizumab_pegol 6
alemtuzumab 19
alirocumab 13
amatuximab 18
andecaliximab 17
anifrolumab 11
anrukinzumab 13
aprutumab 9
aprutumab_ixadotin 9
arcitumomab 10
ascrinvacumab 0
atezolizumab 10
atinumab 10
avelumab 7
basiliximab 18
bavituximab 15
begelomab 11
benralizumab 14
bevacizumab_beta 13
bezlotoxumab 8
bimagrumab 9
bleselumab 5
blinatumomab 16
blosozumab 24
bococizumab 17
brazikumab 12
brentuximab_vedotin 18
briakinumab 12
brodalumab 7
brolucizumab 16
brontictuzumab 21
burosumab 12
cabiralizumab 14
camrelizumab 10
canakinumab 17
cantuzumab_ravtansin 22
carlumab 12
carotuximab 8
cergutuzumab_amunaleukin2 25
cergutuzumab_amunaleukin 25
certolizumab_pegol 19
cetiximab 24
citatuzumab_bogatox 23
cixutumumab 16
clivatuzumab_tetraxetan 11
codrituzumab 18
conatumumab 9
concizumab 14
crenezumab 14
crizanlizumab 17
crotedumab 16
dacetuzumab 20
daclizumab 9
dalotuzumab 18
dapirolizumab_pegol 22
daratumumab 10
dectrekumab 4
demcizumab 18
denosumab 7
depatuxizumab 13
depatuxizumab_mafodotin 13
dezamizumab 12
dinutuximab 23
diridavumab 9
domagrozumab 11
drozitumab 12
duligotuzumab 20
durvalumab 5
dusigitumab 15
efalizumab 29
efungumab 16
eldelumab 10
elezanumab 12
elgemtumab 4
elotuzumab 12
emactuzumab 12
emapalumab 14
emibetuzumab 13
enavatuzumab 19
enfortumab_vedotin 9
enoblituzumab 15
enokizumab 18
enoticumab 13
ensituximab 14
eptinezumab 9
erenumab 10
etaracizumab 12
etrolizumab 18
evinacumab 15
evolocumab 8
farletuzumab 0
fasinumab 13
fezakinumab 13
fibatuzumab 6
ficlatuzumab 22
firivumab 22
flanvotumab 10
fletikumab 20
foralumab 7
foravirumab 12
fremanezumab 24
fresolimumab 10
fulranumab 15
futuximab 10
galcanezumab 10
ganitumab 14
gantenerumab 10
gemetuzumab 18
gemtuzumab2 19
gemtuzumab 12
gevokizumab 15
girentuximab 16
glembatumumab 15
glembatumumab_vedotin 15
guselkumab 14
ibalizumab 20
ibritumomab 16
icrucumab 10
idarucizumab 19
ifabotuzumab 6
imalumab 11
imgatuzumab 15
inclacumab 11
indatuximab_ravtansin 23
indusatumab 10
inebilizumab 16
intetumumab 3
iodine_girentuximab 19
ipilimumab 0
iratumumab 8
isatuximab 16
itolizumab 15
ixekizumab 18
labetuzumab_govitecan 17
lambrolizumab 14
lampalizumab 21
lanadelumab 16
landogrozumab 12
laprituximab 17
lebrikizumab 23
lendalizumab 22
lenzilumab 11
lifastuzumab_vedotin 15
ligelizumab 13
lilotomab 20
lirilumab 17
lodelcizumab 12
lokivetmab 11
lorvotuzumab_mertansin 10
lucatumumab 20
lumretuzumab 13
lupartumab 12
lutikizumab 12
margetuximab 25
milatuzumab 18
mirvetuximab 21
mirvetuximab_soravtansin 21
modotuximab 28
mogamulizumab 17
monalizumab 17
motavizumab 22
moxetumomab_pasudotox 14
namilumab 15
naratuximab 19
naratuximab_emtansin 19
narnatumab 8
navicixizumab2 23
navicixizumab 18
navivumab 11
necitumumab 7
nemolizumab 20
nesvacumab 14
nivolumab 9
obiltoxaximab 12
obinutuzumab 24
ocaratuzumab 13
ofatumumab 11
olaratumab 8
olokizumab 19
omalizumab 15
onartuzumab 21
ontuxizumab 12
opicinumab 13
orticumab 6
otelixizumab 18
oxelumab 7
ozanezumab 17
pamrevlumab 6
panobacumab 18
parsatuzumab 22
pasotuxizumab 16
pateclizumab 12
patritumab 11
pembrolizumab 14
perakizumab 16
pidilizumab 12
pinatuzumab_vedotin 11
plozalizumab 13
pogalizumab 14
polatuzumab_vedotin 17
ponezumab 18
prezalumab 13
pritoxaximab 20
quilizumab 15
racotumomab 22
radretumab 7
ralpancizumab 22
ramucirumab 7
ranevetmab 27
ranibizumab 10
refanezumab 14
remtolumab 10
rilotumumab 11
rinucumab 3
risankizumab 21
rituximab 9
rivabazumab 18
robatumumab 18
roledumab 13
romosozumab 16
rontalizumab 18
rosmantuzumab 13
rozanolixizumab 16
sacituzumab 23
sacituzumab_govitecan 23
samalizumab 19
sapelizumab 18
sarilumab 9
secukinumab 12
seribantumab 13
setoxaximab 27
sifalimumab 6
siltuximab 7
simtuzumab 20
sirukumab 8
solanezumab 21
solitomab 14
stamulumab 11
suptavumab 18
suvizumab 13
tabalumab 6
tadocizumab 7
tamtuvetmab 23
tanezumab 17
tarextumab 8
tavolixizumab 8
telisotuzumab 21
teplizumab 12
tesidolumab 13
tezepelumab 18
tigatuzumab 13
tildrakizumab 16
timolumab 7
tisotumab 9
tosatoxumab 20
tositumomab 13
tralokinumab 16
trastuzumab 24
tregalizumab 18
trevogrumab 8
ublituximab 12
urelumab 10
ustekinumab 20
utomilumab 16
vadastuximab 15
vadastuximab_talirin 15
vandortuzumab_vedotin 12
vantictumab 14
vanucizumab2 13
vanucizumab 12
varlilumab 15
vatelizumab 11
vedolizumab 10
veltuzumab 7
vesencumab 4
vorsetuzumab 19
vorsetuzumab_mafodotin 19
vunakizumab 22
xentuzumab 15
zatuximab 28
